SCHEMBL6203386

SCHEMBL6203386

CS(=O)(=O)Oc1ccc2c(C(=O)c3ccc(OCCC4CCCCN4)cc3)c(-c3ccc(F)c(F)c3CO)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.39
SSTR2 P30874 6/20 0.35
AURKB Q96GD4 1/20 0.34
ENPP3 O14638 4/20 0.33
HRH4 Q9H3N8 1/20 0.32
ESR1 P03372 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
CNR2 P34972 2/20 0.31
ENPP1 P22413 1/20 0.31
LTA4H P09960 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204827 0.94 CHEK2 (0.39) CHEK2SSTR2AURKBENPP3HRH4
SCHEMBL6004786 0.88 CHEK2 (0.41) CHEK2SSTR2AURKBENPP3HRH4
SCHEMBL6203665 0.88 CHEK2 (0.40) CHEK2SSTR2AURKBENPP3HSP90AA1
SCHEMBL6004833 0.84 CHEK2 (0.39) CHEK2SSTR2AURKBENPP3HRH4
SCHEMBL6004662 0.84 CHEK2 (0.39) CHEK2SSTR2AURKBENPP3ENPP1
SCHEMBL6005446 0.84 CHEK2 (0.44) CHEK2SSTR2AURKBHRH4ESR1
SCHEMBL5422671 0.84 ENPP3 (0.48) ENPP3ESR1ENPP1
SCHEMBL6004732 0.82 CHEK2 (0.43) CHEK2SSTR2AURKBESR1
SCHEMBL6005679 0.81 CHEK2 (0.44) CHEK2SSTR2AURKBESR1
SCHEMBL6003264 0.81 CHEK2 (0.43) CHEK2SSTR2AURKBHRH4ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551822-A2 PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 2005-07-13 EP disclosed
WO-2004009578-A2 PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 2004-01-29 WO disclosed